Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aso International (TSE:9340) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Aso International Forward PE Ratio Related Terms
Aso International Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Aso International's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aso International Forward PE Ratio Chart
Aso International Annual Data
Trend
2025-06
Forward PE Ratio
11.55
Aso International Quarterly Data
2024-12
2025-03
2025-06
2025-09
2025-12
2026-03
Forward PE Ratio
6.73
12.11
11.55
13.78
14.19
12.12
TSE:9340 vs ISRG, BDX, MDLN: Forward PE Ratio Comparison
For the Medical Instruments & Supplies subindustry, Aso International's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aso International Forward PE Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aso International's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Aso International's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Aso International (TSE:9340) has a Forward PE Ratio of 12.45 as of Aug. 11, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Aso International and its competitors. According to the industry distribution chart, Aso International ranks #89 out of 391 companies in the Medical Devices & Instruments industry, placing it in the top 22.8%.
Is Aso International's Forward PE Ratio too high?
Aso International's current Forward PE Ratio is 12.45. The Medical Devices & Instruments industry median Forward PE Ratio is 20.22. Aso International's value of 12.45 is 38.4% below this industry median. Based on the distribution chart, Aso International ranks #89 out of 391 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Aso International has a GF Score™ of 62/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aso International's Forward PE Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Aso International ranks #89 out of 391 companies for Forward PE Ratio. This places Aso International in the top 23% of its industry — outperforming the majority of peers. The industry median Forward PE Ratio is 20.22. Aso International's value of 12.45 is 38.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Medical Devices & Instruments company?
The median Forward PE Ratio among Medical Devices & Instruments companies is 20.22, based on 391 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aso International's current Forward PE Ratio of 12.45 is 38.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Aso International and its competitors. For the Medical Devices & Instruments industry, the median Forward PE Ratio is 20.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aso International's current Forward PE Ratio is 12.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aso International stock overvalued right now?
Based on GuruFocus' analysis, Aso International (TSE:9340) is currently considered Modestly Overvalued. The stock's GF Value™ is 円613.94, compared to a current price of 円710.00 — trading 15.6% above its estimated fair value. The current Forward PE Ratio is 12.45 and 38.4% below the Medical Devices & Instruments industry median of 20.22. Aso International's overall GF Score™ is 62/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Aso International (TSE:9340), the current Forward PE Ratio is 12.45 as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aso International (TSE:9340) Overvalued in 2026?
Based on GuruFocus' analysis, Aso International stock appears to be overvalued.
The current stock price of 円710.00 is trading 15.6% above its estimated GF Value™ of 円613.94.
GuruFocus considers Aso International to be Modestly Overvalued.
Key valuation signals for TSE:9340:
Forward PE Ratio: 12.45
GF Value™: 円613.94 vs. price of 円710.00 (15.6% above fair value)
Industry Position: 38.4% below the Medical Devices & Instruments median (#89 of 391)
No single metric tells the full story. See the TSE:9340 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aso International Inc is engaged in the manufacturing and sale of orthodontic appliances. The company mainly manufactures and supplies custom-made orthodontic dental prostheses to dental medical institutions. Its product portfolio comprises Aso Liner, Specter 4D Print Retainer, 3D printers for dental prostheses, Harmony, a lingual orthodontic system, and various types of retainers, among others. The group operates in a single segment, the orthodontic business.
62GF Score
Get the complete analysis for TSE:9340
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9340 has been successfully added to your 
